ストックスクリーナーアプリを入手
1.19
9.85%
-0.13
前日終値:
$1.32
開ける：
$1.32
24時間の取引高:
466.42K
Relative Volume:
0.99
時価総額：
$75.46M
収益：
$4.39M
当期純損益:
$-22.40M
株価収益率:
-2.3342
EPS:
-0.5098
ネットキャッシュフロー:
$-22.79M
1週間 パフォーマンス:
-15.60%
1か月 パフォーマンス:
-35.85%
6か月 パフォーマンス:
-39.90%
1年 パフォーマンス:
-3.25%
1日の値動き範囲:
$1.185
$1.35
1週間の範囲:
$1.185
$1.51
52週間の値動き範囲:
$0.7562
$3.54
Equillium Inc Stock (EQ) Company Profile
Compare EQ vs VRTX, MRNA, REGN, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
1.19 | 75.46M | 4.39M | -22.40M | -22.79M | -0.5098 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-10-12 | 再開されました | Leerink Partners | Outperform |
| 2026-07-13 | 開始されました | Piper Sandler | Overweight |
| 2026-05-28 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2026-04-23 | 開始されました | Oppenheimer | Outperform |
| 2026-04-16 | 開始されました | B. Riley Securities | Buy |
| 2026-04-14 | 開始されました | Raymond James | Strong Buy |
| 2026-04-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2026-03-13 | 開始されました | Roth Capital | Buy |
| 2026-02-25 | 開始されました | Stifel | Buy |
| 2025-03-28 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2021-10-29 | 再開されました | Stifel | Buy |
| 2021-09-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-07-14 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-10 | 再開されました | Stifel | Buy |
| 2019-02-22 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Equillium Inc (EQ) 最新ニュース
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504 - Stock Titan
Equillium at Cantor conference: EQ504 advances as lead ahr program By Investing.com - Investing.com Nigeria
Equillium at Cantor conference: EQ504 advances as lead ahr program By Investing.com - Investing.com UK
Equillium Stock Price Forecast. Should You Buy EQ? - StockInvest.us
EQ Reiterates by Roth Capital -- Price Target Maintained at $12 - GuruFocus
EQ Q2 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineEarnings Momentum Score - vinanet.vn
Equillium to Participate in Upcoming Investor Conferences - GlobeNewswire
Equillium to Participate in Upcoming Investor Conferences - GlobeNewswire
EQ | Equillium, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Equillium (EQ) Q1 2026 Earnings: The EPS Result Is Below Expectation in the Available Record; Closing Reaction: Shares Finish 0.85% Lower at the CloseEarnings Acceleration Picks - vinanet.vn
Equillium (EQ) Earnings Report: EPS Misses Its Estimate in the Latest Session; Trading Response - vinanet.vn
Equillium (EQ) Earnings Report: EPS Misses Its Estimate in the Latest Session; Trading Response - dars.gov.et
3 Promising Penny Stocks With Market Caps Under $400M - simplywall.st
Equillium (NASDAQ:EQ) Rating Increased to Hold at Wall Street Zen - MarketBeat
EQ Q1 2026 Earnings: EPS Miss of 34.5% Drives 7.8% Stock DeclineDividend Increase Stocks - vinanet.vn
Oppenheimer Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Roth MKM Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Equillium (NASDAQ:EQ) Announces Earnings Results - MarketBeat
Equillium Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Form 8K Equillium Inc For: 13 August By Investing.com - Investing.com Nigeria
Equillium Inc. (EQ) Drops 7.8% to $2.01 as Support at $1.91 Comes Into FocusKAMA Signal - vinanet.vn
Equillium, Inc. Q2 2026: Net loss $(4.7)M, EPS $(0.04) — 10-Q Summary - TradingView
Equillium Q2 post narrower net loss than expected; starts R&D initiatives - TradingView
Form 8K Equillium Inc For: 13 August By Investing.com - Investing.com India
Equillium, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Form 8K Equillium Inc For: 13 August By Investing.com - Investing.com Canada
Affinity Asset Advisors reports 4.1M Equillium (EQ) shares, a 6.5% stake - Stock Titan
Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - The Manila Times
Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewswire
EQ Q1 2026 Earnings: EPS Misses Estimates with Wider-than-Expected Loss of -$0.06Fiscal Year Earnings - vinanet.vn
Equillium (NASDAQ:EQ) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
Equillium Inc. (EQ) Drops 7.8% to $2.01 as Support at $1.91 Comes Into FocusALMA Signal - dars.gov.et
Equillium Inc (NASDAQ: EQ) Share Price, EQ Stock News, EQ Share Price & Updates - kalkine.com.au
Equillium Inc (NASDAQ: EQ) Share Price, EQ Stock News, EQ Share Price & Updates - kalkine.ca
Adage Capital discloses 7.25% Equillium (EQ) stake via Schedule 13G/A filing - Stock Titan
EQ Q1 2026 Earnings: Wider-than-Expected Loss Leaves Shares LowerAnnual Financial Report - vinanet.vn
EQ Q2'26 Earnings: EPS estimate is (0.05) USD - TradingView
Equillium Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
Equillium, Inc. (NASDAQ:EQ) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Equillium Inc (EQ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Equillium (EQ) Holds Near $2.11 as Stock Tests $2.0 SupportWyckoff Distribution - vinanet.vn
Equillium (EQ) Projected to Announce Earnings on Thursday - MarketBeat
EQ Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Equillium, Inc. $EQ Holdings Lifted by Janus Henderson Group PLC - MarketBeat
Clear Street Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $9 - Moomoo
EQ Q1 2026 Earnings: Wider-than-Expected Loss Sends Shares Down 5.17%EPS Revision Trend - vinanet.vn
Equillium Inc. (EQ) Shows Modest Gain as Shares Test Key ResistanceHigh Volume Node - dars.gov.et
Equillium Inc. (EQ) Shows Modest Gain as Shares Test Key ResistanceHigh Beta Stocks - vinanet.vn
ADAR1 Capital Management LLC Has $7.45 Million Position in Equillium, Inc. $EQ - MarketBeat
1,498,993 Shares in Equillium, Inc. $EQ Purchased by Eversept Partners LP - MarketBeat
Equillium Inc (EQ) 財務データ
収益
当期純利益
現金流量
EPS
Equillium Inc (EQ) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Connelly Stephen | President and CSO |
Jun 05 '26 |
Sale |
2.94 |
30,975 |
91,070 |
762,025 |
| Zedelmayer Christine | Sr. Vice President and COO |
Jun 05 '26 |
Sale |
2.93 |
14,584 |
42,737 |
62,586 |
| Zedelmayer Christine | Sr. Vice President and COO |
Jun 05 '26 |
Option Exercise |
0.79 |
14,584 |
11,448 |
77,170 |
| Connelly Stephen | President and CSO |
Jun 04 '26 |
Sale |
3.16 |
200,000 |
632,760 |
793,000 |
| Connelly Stephen | Officer |
Jun 04 '26 |
Proposed Sale |
3.16 |
200,000 |
632,760 |
0 |
| Tom Penny | Principal Accounting Officer |
May 28 '26 |
Sale |
2.95 |
65,000 |
191,750 |
0 |
| Zedelmayer Christine | Sr. Vice President and COO |
May 28 '26 |
Option Exercise |
0.77 |
86,012 |
66,391 |
118,390 |
| Zedelmayer Christine | Sr. Vice President and COO |
May 28 '26 |
Sale |
2.80 |
86,012 |
240,693 |
62,586 |
| Tom Penny | Principal Accounting Officer |
May 28 '26 |
Option Exercise |
0.79 |
65,000 |
51,025 |
65,000 |
| Zedelmayer Christine | Sr. Vice President and COO |
May 27 '26 |
Option Exercise |
0.77 |
9,821 |
7,562 |
72,407 |
4.22%
大文字化:
|
ボリューム (24 時間):